Keyword: Particle Sciences

News

Lubrizol Hikes Drug Product Manufacturing Capacity

07.06.2017 - Lubrizol has announced a $60 million investment in new product solutions, capacity expansion, and additional cGMP manufacturing to strengthen its excipients, polymers, drug...

News

Particle Sciences Adds Filling Capacity

17.06.2016 - Drug product formulation specialist Particle Sciences, part of Lubrizol’s LifeSciences business since September 2015, has added capacity for cGMP sterile powder filling and capsule...

News

Lubrizol Acquires Particle Sciences

11.09.2015 - US-based Lubrizol Corporation has acquired Particle Sciences, a compatriot contract drug developer and manufacturer headquartered at Bethlehem, Pennsylvania. Terms of the...